D-1225-2015 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1225-2015 was initiated by American Health Packaging on Jun 1, 2015 and is designated Class II. Reason for recall: CGMP Deviations: Firm did not adequately investigate customer complaints. The recall status is terminated (terminated Feb 22, 2017). Affected quantity: 97,837 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 15, 2015
Initiation Date
Jun 1, 2015
Termination Date
Feb 22, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
97,837 cartons

Product description

Famotidine tablets, USP 20mg, packaged in 10-count blisters (NDC 68084-172-11); 10 blister packs per carton (NDC 68084-172-01); Rx only, Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.

Reason for recall

CGMP Deviations: Firm did not adequately investigate customer complaints.

Distribution pattern

Nationwide

Code information

Lot#: 132146, Exp 06/30/2015; Lot#: 132147, 132963, Exp 08/31/2015; Lot#: 132964, Exp 10/31/2015; Lot#: 134319, Exp 12/31/2015; Lot#: 134320, Exp 01/31/2016.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1225-2015
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1225-2015. Report a data issue: hello@regdatalab.com.